Patient insights for shaping myositis research
Part of Bones, joints & muscles, Brain & nervous system, Skin clinical trials.
This study asks people with autoimmune muscle diseases (myositis) and their caregivers to share their experiences and insights. By joining, you help shape better research and care for myositis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or a loved one must have been diagnosed by a doctor with an inflammatory myopathy (a type of autoimmune muscle disease).
- You must be at least 7 years old.
- You can be a patient, or the care partner or parent of a patient.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study helps doctors better understand myositis—a group of rare diseases that cause muscle inflammation and weakness. Researchers collect blood samples, medical history, and sometimes muscle biopsies to learn more about what causes these conditions and how to treat them better.
This study is testing a new questionnaire called the BETY-BQ to see if it is a good tool for measuring how well people with myositis are doing—things like symptoms and function. The goal is to make it easier for doctors to track your progress over time.
This study looks for environmental risk factors that may be linked to anti-synthetase syndrome, a type of inflammatory muscle disease. It compares people with the condition to carefully matched people without it, using questionnaires, blood samples, and lung imaging when needed.
This research study examines how diet relates to muscle disease in people with inclusion body myositis (IBM), a rare muscle-weakening condition. Researchers will compare eating habits and nutritional patterns between people with IBM and healthy volunteers to understand how nutrition affects muscle health.
This Phase 3 trial tests how an investigational medicine (PF-06823859) works in adults with active dermatomyositis or polymyositis. It aims to improve disease control by targeting the immune system, but you must meet several safety and diagnosis requirements.
This trial is for adults with inflammatory muscle disease (myositis) that affects the heart. It aims to study the disease and find better ways to manage heart-related complications.
Hear when a new IIM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.